A standard approach to compiling clinical pharmacokinetic data
- 1 February 1981
- journal article
- other
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 9 (1) , 59-127
- https://doi.org/10.1007/bf01059343
Abstract
A standard format for a Clinical Pharmacokinetic Summary is proposed. It consists of a heading, table, notes, and references for each drug reviewed. The table presents a unified and logical set of clinically useful population pharmacokinetic parameters. They concern four major areas: absorption, distribution, elimination, and the relationship of concentration to effect. Within each major group, parameters dealing with extents and rates of processes are given. Each such parameter is really two: a population mean value (for example, average volume of distribution) and the standard deviation of individual values about this mean. The first value allows individual predictions of dosage or drug level to be made; the second allows computation of the likely proximity of subsequently observed quantities to those predictions. The table presents single consensus values for each population parameter, rather than a list of values. A procedure for computing these consensus values, and for revising them in the light of new data, or reinterpreted old data, is given. Examples of Summaries are given. The method appears applicable to a variety of drugs. We suggest our approach as a standard one for preparing Clinical Pharmacokinetic Summaries, and urge our colleagues to consider it for that purpose.Keywords
This publication has 110 references indexed in Scilit:
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979
- Effect of Furosemide on Serum Clearance and Renal Excretion of DigoxinThe Journal of Clinical Pharmacology, 1979
- Enhanced Transformation of Digitoxin to Dihydrodigitoxin in Humans with Renal FailureThe Journal of Clinical Pharmacology, 1979
- Pharmacokinetics of digoxin: Relationship between response intensity and predicted compartmental drug levels in manJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatographyLife Sciences, 1979
- Cerebrospinal Fluid Digoxin Concentrations in HumansThe Journal of Clinical Pharmacology, 1978
- Relationship of Serum and Myocardial Digoxin Concentration to Electrocardiographic Estimation of Digoxin IntoxicationThe Journal of Clinical Pharmacology, 1978
- Importance of “first-pass elimination” for interindividual differences in steady-state concentrations of the adrenergicβ-receptor antagonist alprenololJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Combined pharmacokinetic and pharmacodynamic studies on alprenolol and 4-hydroxy-alprenolol in manLife Sciences, 1974
- Identification of the major urinary metabolite of alprenolol in man, dog and ratLife Sciences, 1974